You appear to be offline. Some data may be unavailable until your connection is restored.
Description
AbbVie Inc. is a research‑focused biopharmaceutical company that discovers, develops, manufactures and markets prescription medicines and biologics. Its portfolio spans immunology drugs such as Humira, Skyrizi and Rinvoq, oncology therapies including Imbruvica and Venclexta, neuroscience products like Vraylar and migraine treatments, as well as aesthetics brands such as Botox. AbbVie operates in the global pharmaceutical and healthcare sector, emphasizing innovative therapies for complex, chronic diseases. The firm is regarded as a leading U.S. biotech firm, noted for its blockbuster immunology franchise and a growing pipeline across multiple therapeutic areas.
Dividend
Dividend history
| Amount | Ex-Date | Payment Date |
|---|---|---|
| $1.73 | Jul 15, 2026 | Aug 14, 2026 |
| $1.73 | Apr 15, 2026 | May 15, 2026 |
| $1.73 | Jan 16, 2026 | Feb 17, 2026 |
Track every ABBV dividend
Get reminders ahead of ABBV's ex-dividend and payment dates, so you always know when distributions are coming. Pair them with price and earnings alerts to keep your full income picture in view.